Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Clinical trial NCT02419755 · TERMINATED
Trial details
- NCT number
- NCT02419755
- Sponsor
- St. Jude Children's Research Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-14
- Primary completion
- 2016-12-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.